Immediate Impact
2 by Nobel laureates 33 from Science/Nature 66 standout
Citing Papers
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies
2022 Standout
Works of Rossano Cesari being referenced
Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer
2018
In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of β-thalassemia
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rossano Cesari | 1131 | 657 | 353 | 441 | 34 | 2.1k | |
| Eric S. Martin | 1535 | 572 | 327 | 500 | 53 | 2.6k | |
| Debra M. Lillington | 1146 | 625 | 358 | 491 | 50 | 2.9k | |
| A. Thomas Look | 1194 | 588 | 239 | 320 | 39 | 2.3k | |
| Josiane Grosgeorge | 1982 | 656 | 287 | 231 | 32 | 3.1k | |
| Kurt Grünewald | 892 | 667 | 202 | 197 | 29 | 2.1k | |
| Thomas Look | 2095 | 873 | 298 | 324 | 36 | 3.1k | |
| Blanca Scheijen | 1505 | 600 | 175 | 303 | 52 | 2.5k | |
| C.A. Griffin | 790 | 419 | 264 | 191 | 40 | 2.1k | |
| Iris Moll | 1269 | 868 | 203 | 534 | 28 | 2.5k | |
| J Finan | 1108 | 635 | 373 | 772 | 48 | 2.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...